Cancer and Metastasis Reviews

Papers
(The H4-Index of Cancer and Metastasis Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer206
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities143
Regulation of dormancy during tumor dissemination: the role of the ECM104
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms86
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression77
Clonal tracking in cancer and metastasis74
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective71
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions66
The functions and modifications of tRNA-derived small RNAs in cancer biology65
Obesity and cancer53
The role of microbiome in pancreatic cancer49
Targeting lipid metabolism in cancer: neuroblastoma48
The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor48
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer48
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations48
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review47
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?47
CAR T-cell therapy to treat multiple myeloma: current state and future directions47
Cell-cell interactions mediating primary and metastatic breast cancer dormancy44
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond43
A multidisciplinary perspective on the complex interactions between sleep, circadian, and metabolic disruption in cancer patients40
p73 isoforms meet evolution of metastasis40
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives39
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?39
Preface37
Biography—Mathieu Boissan, Pharm.D., Ph.D36
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer35
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance34
Neuropeptide Y in cancer—biological functions and potential clinical implications33
Biographies31
How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy31
0.03310489654541